PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

LUMIGAN Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "LUMIGAN Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

LUMIGAN Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on LUMIGAN and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for LUMIGAN
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Allergan Inc.
  • Ispharm
  • Abi Chem
  • Chemmol
  • Akos Consulting & Solutions
  • Active Biopharma
  • Wutech
  • Apexmol
  • Abachemscene
  • An Pharmatech
  • Irvine Chemistry Lab
  • Avachem Scientific
  • Race Chemical
  • Molepedia
  • Ark Pharm Inc.
  • Targetmol
  • Boc Sciences
  • Parchem
  • Ichemical Technology USA Inc
  • Chem-Space.com Database
  • Enovation Chemicals
  • Abovchem Llc
  • Acorn Pharmatech
  • Sigma-Aldrich
  • Achemo Scientific Limited
  • Pi Chemicals
  • LGC Standards
  • Ochem
  • Molport
  • Musechem
  • Combi-Blocks
  • Bld Pharm
  • Ambeed
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/l4r7xn/lumigan_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005408/en/

Editor Details

Last Updated: 14-Jan-2019